Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2010 2
2011 1
2012 2
2013 4
2014 2
2015 4
2016 2
2017 6
2018 3
2019 5
2020 4
2021 6
2022 9
2023 18
2024 3
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.
Brown DM, Emanuelli A, Bandello F, Barranco JJE, Figueira J, Souied E, Wolf S, Gupta V, Ngah NF, Liew G, Tuli R, Tadayoni R, Dhoot D, Wang L, Bouillaud E, Wang Y, Kovacic L, Guerard N, Garweg JG. Brown DM, et al. Among authors: dhoot d. Am J Ophthalmol. 2022 Jun;238:157-172. doi: 10.1016/j.ajo.2022.01.004. Epub 2022 Jan 14. Am J Ophthalmol. 2022. PMID: 35038415 Free article. Clinical Trial.
Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema.
Lim JI, Amador MJ, Dhoot DS, Finn A, Fraser-Bell S, Gibson K, Idowu OO, Khurana RN, Lanzetta P, Lin TC, Mar FA, Pollreisz A, Rachitskaya A, Schlottmann PG, Tang Y, Lai TYY. Lim JI, et al. Among authors: dhoot ds. Ophthalmol Retina. 2025 Jul;9(7):655-666. doi: 10.1016/j.oret.2025.01.017. Epub 2025 Feb 4. Ophthalmol Retina. 2025. PMID: 39914485 Free article. Clinical Trial.
Author's reply.
Babu PR, S Pravin AJ, Deshmukh G, Dhoot D, Samant A, Kotak B. Babu PR, et al. Among authors: dhoot d. Indian J Dermatol. 2017 Nov-Dec;62(6):667-669. doi: 10.4103/ijd.IJD_496_17. Indian J Dermatol. 2017. PMID: 29263546 Free PMC article. No abstract available.
Pediatric infectious posterior uveitis.
Dhoot DS, Martin DF, Srivastava SK. Dhoot DS, et al. Int Ophthalmol Clin. 2011 Winter;51(1):113-28. doi: 10.1097/IIO.0b013e318200e0ed. Int Ophthalmol Clin. 2011. PMID: 21139480 Review. No abstract available.
Chyluria Associated With Nephrotic-Range Proteinuria.
Kaur A, Kandari S, Saini S, Dhoot DK, Kandari A. Kaur A, et al. Among authors: dhoot dk. Cureus. 2022 Jul 9;14(7):e26690. doi: 10.7759/cureus.26690. eCollection 2022 Jul. Cureus. 2022. PMID: 35959171 Free PMC article.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
76 results